| Accession No. | COA-A26Q2GLW0104 |
| Client | Alpha Nordisk |
| Report Date | 6/9/2026 |
| Product | GLOW | Lot | A26Q2GLW0104 |
| Chemical | GHK-Cu · TB-500 · BPC-157 blend | Mfg Date | 2026-Q2 |
| Form | Lyophilized Powder | Exp Date | EXP 05/28 |
| Dose | 70mg | Purity | 99.2% |
| Formula | Blend | Net Content | 68.9 mg |
| Mol. Weight | 403.9 Da | Appearance | White lyophilized powder |
| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Appearance | Visual inspection | White lyophilized powder | Conforms | ✓ PASS |
| Identity | ESI-MS (≤5 ppm) | Confirmed [M+H]⁺ = 404.9 | Confirmed | ✓ PASS |
| Purity | HPLC-UV (C18, 220 nm) | ≥99.0% | 99.2% | ✓ PASS |
| Related substances | HPLC-UV | ≤1.0% total | <0.8% | ✓ PASS |
| Endotoxin | LAL (gel-clot) | <1.0 EU/mg | <0.5 EU/mg | ✓ PASS |
| Water content | Karl Fischer | <8.0% | <5.2% | ✓ PASS |
| Counterion | Ion chromatography | Acetate (TFA-free) | Acetate | ✓ PASS |
| Sterility | USP <71> visual | No visible contamination | Conforms | ✓ PASS |
HPLC-UV Chromatogram (220 nm)
* Representative chromatogram shown for GHK-Cu (dominant component)
ESI Mass Spectrum
This Certificate of Analysis is issued by Alpha Nordisk for research and laboratory use documentation. The peptide described is intended exclusively for research and laboratory use. Not for human consumption, clinical, diagnostic, or therapeutic application. Lot traceability and analytical data are maintained by Alpha Nordisk under Danish Formulation Technology standards.